Skip to main content

Ogechukwu P. Eze, MD, MHS

Board Certifications

Anatomic and Clinical Pathology

Fellowship

Gastrointestinal & Liver Pathology

Locations

ProPath

Biography

  • Residency – Anatomic and Clinical Pathology, New York University Langone Medical Center, New York, New York
  • Medical School – Yale School of Medicine, New Haven, Connecticut
  • Joined ProPath in 2021

Peer-Reviewed Articles

  1. Sahn B, Eze OP, Edelman MC, Chougar CE, Thomas RM, Schleien CL, Weinstein T. Features of intestinal disease associated with COVID-related multisystem inflammatory syndrome in children. J Pediatr Gastroenterol Nutr. 2021;72(3):384-387.

  2. Singh N, El-Hinnawi A, Hill B, Elkhammas E, Eze O, Alebrahim M, Michaels A, Schenk A, Washburn K, Black S. Hepatic resection and transplant in glycogen storage diseases. Exp Clin Transplant. 2020 Feb 7. doi: 10.6002/ect.2019.0313. [Epub ahead of print]

  3. Buja LM, Zehr B, Lelenwa L, Ogechukwu E, Zhao B, Dasgupta A, Barth RF. Clinicopathological complexity in the application of the universal definition of myocardial infarction. Cardiovasc Pathol. 2020 Jan-Feb;44:107153.

  4. Pezhouh MK, Miller JA, Sharma R, Borzik D, Eze O, Waters K, Westerhoff MA, Parian AM, Lazarev MG, Voltaggio L. Refractory inflammatory bowel disease: is there a role for Epstein-Barr virus? A case-controlled study using highly sensitive Epstein-Barr virus-encoded small RNA1 in situ hypridization.  Hum Pathol. 2018;82:187-192.

  5. Salimian KJ, Waters KM, Eze O, Pezhouh MK, Tarabishy Y, Shin EJ, Canto MI, Voltaggio L, Montgomery EA. Definition of Barrett Esophagus in the United States: support for retention of a requirement for goblet cells. Am J Surg Pathol. 2018;42(2):264-268.

  6. Eze O, Jones R, Montgomery E. A practical approach for diagnosis of appendiceal mucinous neoplasms. Diagn Histopathol. 2017;23(12):530-535.

  7. Ettel M, Gonzalez GA, Gera S, Eze O, Sigal S, Park JS, Xu R. Frequency and pathological characteristics of drug-induced liver injury in a tertiary medical center. Hum Pathol. 2017;68:92-98.

  8. Eze OP, Montgomery EA. Inflammatory cell-rich soft tissue tumors. AJSP: Reviews and Reports. 2017;22(2):75-84.

  9. Kaimakliotis P, Giardiello F, Eze O, Truta B. A rare case of Crohn’s ileitis in a patient with constitutional mismatch repair deficiency. Ann Gastroenterol. 2017;30(3):370-372.

  10. Guo S, Melamed J, Eze O, Bowman C, Ahmed S, Moore HG, Loomis C, Heguy A, Brody R, Morrison DJ, Serrano J, Du KL, Wu JJ, Ryan T, Cohen DJ, Gu P, Goldberg JD, Snuderl M, Leichman LP, Leichman CG. Methylation profiling of locally advanced rectal cancer (LARC): exploration of potential predictive markers for neoadjuvant chemoradiation (NACR). J Clin Oncol. 2016;34(4suppl):614.

  11. Ettel M, Eze O, Xu R. Clinical and biological significance of precursor lesions of intrahepatic cholangiocarcinoma. World J Hepatol. 2015;7(25):2563-70.

  12. Eze O, Harari S, Cho M, Neto AG. Colonic polyp presenting as a tubulovillous adenoma and harbinger of high-grade neuroendocrine carcinoma: a unique presentation. Case Reports Clin Pathol. 2015;2(1).

  13. Andersson U, Wibom C, Cederquist K, Aradottir S, Borg A, Armstrong GN, Shete S, Lau CC, Bainbridge MN, Claus EB, Barnholtz-Sloan J, Lai R, Il’yasova D, Houlston RS, Schildkraut J, Bernstein JL, Olson SH, Jenkins RB, Lachance DH, Wrensch M, Davis FG, Merrell R, Johansen C, Sadetzki S, Gliogene Consortium [Eze O, member], Bondy ML, Melin BS. Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer. Neuro Oncol. 2014;16(10):1333-40.

  14. Cho M, Eze OP, Xu R. Molecular genetics of gastric adenocarcinoma in clinical practice. World J Med Genet. 2014; 4(3):58-68.

  15. Cho M, Eze OP, Xu R. A brief review of the controversial role of iron in colorectal carcinogenesis. J Clin Exp Pathol. 2013;3:137.

  16. Chiatar SS, Eze OP, Schoenfeld AR. Expression of VHL causes three-dimensional morphological changes in renal cells indicative of proximal tubule differentiation. Cell Dev Biol. 2013;2:118.

  17. Eze OP, Cai G, Baloch ZW, Khan A, Hammers LW, Udelsman R, Chhieng D, Theoharis CGA, Prasad ML. Vanishing thyroid tumors: a rare diagnostic dilemma after ultrasound-guided fine-needle aspiration. Thyroid. 2013;23(2):194-200.

  18. Eze OP, Starker LF, Carling T. The role of epigenetic alterations in papillary thyroid carcinogenesis.  J Thyroid Res. 2011;2011:895470.

Abstracts

  1. Eze O, Hammond S, Cui X, Li Z, Shen R, Suarez A, Frankel W, Schoenfield L, Parwani A. Validation of multiple high-throughput whole slide imaging (WSI) systems for primary diagnoses and clinical applications at a large academic institution. USCAP Annual Meeting, National Harbor, MD, March 2019.

  2. Eze O, Tarabishy Y, Waters K, Pezhouh MK, Veits L, May A, Ell C, Montgomery E, Vieth M. Lateral spread in esophageal squamous cell neoplasia [proffered paper]. USCAP Annual Meeting, San Antonio, TX, March 2017.

  3. Eze OP, Tarabishy Y, Waters KM, Pezhouh MK, Giardiello FM, Voltaggio L, Montgomery EA. Upper gastrointestinal lesions in Peutz-Jeghers syndrome. USCAP Annual Meeting, San Antonio, TX, March 2017.

  4. Pezhouh M, Eze OP, Tarabishy Y, Waters K, Parian A, Lazarev M, Montgomery EA, Voltaggio L. Epstein-Barr Virus infection in refractory inflammatory bowel disease patients undergoing colectomy [proffered paper]. USCAP Annual Meeting, San Antonio, TX, March 2017.

  5. Tarabishy Y, Eze OP, Pezhouh M, Voltaggio L, Montgomery EA, Waters K. Long-term follow-up and non-specific staining for ER and GATA-3 in type-1 gastric neuroendocrine tumors. USCAP Annual Meeting, San Antonio, TX, March 2017.

  6. Tarabishy Y, Eze OP, Waters K, Voltaggio L, Montgomery EA, Pezhouh M. Clinical and pathologic features of gastrointestinal Rosai Dorfman disease. USCAP Annual Meeting, San Antonio, TX, March 2017.

  7. Pezhouh M, Miller JA, Hutchings D, Shabihkhani M, Eze OP, Voltaggio L, Montgomery EA.  Lymphocytic gastritis: clinicopathologic associations, old and new. USCAP Annual Meeting, San Antonio, TX, March 2017.

  8. Waters L, Eze OP, Pezhouh M, Tarabishy Y, Voltaggio L, Montgomery EA. Loss of SMAD4 immunohistochemical expression in esophageal adenocarcinoma. USCAP Annual Meeting, San Antonio, TX, March 2017.

  9. Acosta-Gonzalez G, Ettel M, Eze O, Gera S, Hajdu CH, Park JS, Sigal S, Xu R. Clinical and pathologic features of nutritional and herbal supplements induced liver injury [abstract 1629]. Mod Pathol. 2016;29(2S):413A.

  10. Ettel M, Acosta-Gonzalez G, Eze O, Gera S, Hajdu CH, Park JS, Sigal S, Xu R. Frequency and pathological characteristics of drug-induced liver injury in a tertiary medical center [abstract 1654]. Mod Pathol. 2016;29(2S):419A.

  11. Guo S, Melamed J, Eze O, Bowman C,  Moore H, Loomis C‎,Heguy A, Brody R, Morrison D, Serrano J, Du K, Wu J, Ryan T, Cohen D, Gu P, Goldberg JD, Snuderl M,  Leichman L, Leichman C. Methylation profiling of locally advanced rectal cancer (LARC): exploration of potential predictive markers for neoadjuvant chemoradiation (NACR). Gastrointestinal Cancers Symposium, San Francisco, CA, January 2016.

  12. Eze O, Cho M, Santoriello D, Wu M, Xu R. Thalidomide analog-induced liver damage: a case report. CAP Meeting, Chicago, IL, September 2014.

  13. Eze O, Xu W, Deng FM, Melamed J, Zhou M. Prostate biopsies with discontinuous cancer involvement: gap or no gap? USCAP Annual Meeting, San Diego, CA, March 2014.

  14. Eze O, Cai G, Baloch ZW, Khan A, Hammers LW, Udelsman R, Chhieng D, Theoharis CGA, Prasad ML. Vanishing thyroid nodules: a rare diagnostic dilemma induced by ultrasound guided fine needle aspiration. American Society for Clinical Pathology Annual Conference, Las Vegas, NV, October 2011.

  15. Eze O, Starker LF, Long WD, Udelsman R, Björklund P, Carling T. Braf-associated papillary thyroid cancer: epigenetic events suggest distinct molecular pathogenesis. National Predoctoral Clinical Research Training Program Meeting, St. Louis, MO, May 2011.

  16. Eze O, Starker LF, Long WD, Udelsman R, Björklund P, Carling T. Braf-associated papillary thyroid cancer: epigenetic events suggest distinct molecular pathogenesis. 6th Annual Academic Surgical Congress, Huntington Beach, CA, February 2011.

  17. Eze O, Hobbie L. Genetic enhancers of the auxin-resistant4 mutation of Arabidopsis. New York Area Plant Molecular Biology Meeting, Yale University, CT, April 2007.

  18. Hobbie L, Eze O, Gould P, Adler M, Anselmo R, Arredondo S, Garcia JP,  Hammond M, Herrera K, Mead A, Petrov V, Sanchez A, Sinha P, Thompson C. Physiological and genetic characterization of the enhancers of the auxin-resistant4 mutation of Arabidopsis. IPGSA 19th Annual Meeting, Puerto Vallarta, Mexico, July 2007.
Previous
Next